Total | Bronchitis (OR (95% CI)) | Pneumonia (OR (95% CI)) | Asthma (OR (95% CI)) | Any respiratory disease (OR (95% CI)) | |
Chronic phlegm* | 3982 | 2.12 (1.51, 2.99) | 1.13 (0.74, 1.71) | 1.61 (0.96, 2.67) | 1.64 (1.25, 2.16) |
Model 2† | 2.08 (1.48, 2.93) | 1.11 (0.73, 1.68) | 1.58 (0.95, 2.64) | 1.63 (1.23, 2.15) | |
Model 3‡ | 1.60 (1.06, 2.43) | 1.05 (0.65, 1.69) | 1.32 (0.72, 2.43) | ||
Dyspnoea* | 3750 | 1.48 (1.07, 2.06) | 1.17 (0.83, 1.65) | 1.72 (1.11, 2.66) | 1.42 (1.11, 1.82) |
Model 2† | 1.45 (1.05, 2.02) | 1.15 (0.81, 1.63) | 1.68 (1.08, 2.61) | 1.40 (1.10, 1.79) | |
Model 3‡ | 1.36 (0.97, 1.91) | 1.06 (0.74, 1.51) | 1.54 (0.98, 2.42) | ||
Asthma* | 3823 | 4.19 (3.08, 5.68) | 2.26 (1.60, 3.18) | 39.86 (27.06, 58.71) | 6.95 (5.46, 8.86) |
Model 2† | 4.18 (3.08, 5.68) | 2.25 (1.60, 3.18) | 39.84 (27.05, 58.69) | 6.95 (5.46, 8.86) | |
Model 3‡ | 2.62 (1.79, 3.82) | 1.36 (0.89, 2.08) | 33.38 (22.48, 49.58) | ||
Bronchitis or emphysema* | 3819 | 8.38 (6.37, 11.01) | 1.62 (1.14, 2.30) | 7.74 (5.43, 11.05) | 5.25 (4.18, 6.60) |
Model 2† | 8.25 (6.26, 10.87) | 1.59 (1.12, 2.26) | 7.74 (5.41, 11.08) | 5.22 (4.15, 6.56) | |
Model 3‡ | 7.07 (5.29, 9.45) | 0.92 (0.62, 1.39) | 5.59 (3.76, 8.30) | ||
CVD* | 3858 | 1.09 (0.78, 1.52) | 1.05 (0.75, 1.47) | 0.96 (0.59, 1.54) | 1.10 (0.86, 1.40) |
Model 2† | 1.06 (0.76, 1.49) | 1.04 (0.74, 1.45) | 0.94 (0.58, 1.51) | 1.08 (0.85, 1.38) | |
Model 3‡ | 1.07 (0.76, 1.51) | 1.03 (0.74, 1.45) | 0.92 (0.56, 1.50) | ||
Cancer* | 3743 | 1.03 (0.64, 1.67) | 1.31 (0.85, 2.03) | 0.58 (0.25, 1.34) | 1.19 (0.86, 1.67) |
Model 2† | 1.03 (0.64, 1.67) | 1.31 (0.85, 2.03) | 0.58 (0.25, 1.34) | 1.20 (0.86, 1.67) | |
Model 3‡ | 1.05 (0.64, 1.71) | 1.35 (0.87, 2.11) | 0.55 (0.24, 1.28) |
Glasgow Alumni Cohort, 2001–2002.
*Age adjusted.
†Adjusted for adult smoking.
‡Adjusted for all early life respiratory diseases and adult smoking.